Sildosin 4 mg in patients below 45 years old versus those older than 45 years old and suffering from premature ejaculation

sildoin and premature ejaculation - sildoin and premature ejaculation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039192

Enrollment

100

Registered

2020-01-18

Start date

2020-01-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

male sexual dysfunction

Interventions

patients below 45 years will receive sildosin 4mg daily patients above 45 years will receive sildosin 4mg daily

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Males with PE and LUTS

Exclusion criteria

Exclusion criteria: Males with ED

Design outcomes

Primary

Measure	Time frame
sildosin and improvement of LUTS	—

Secondary

Measure	Time frame
sildosin and PE	—

Countries

Africa

Contacts

Public Contactsameh gamalel din

Kasr AlAiny faculty of medicine Andrology & STDs

samehfayek@hotmail.com01227109309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026